Bottom line
XLV vs PINK: the short answer
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and PINK (Simplify Health Care ETF) share a meaningful slice of their top holdings — about 41% by weight.
XLV is cheaper at 0.08% vs 0.51% — a difference of $43 a year per $10,000 invested.
Over one year, PINK returned +24.1% vs +14.5% for XLV.
Updated Nov 19, 2026
XLV vs PINK side by side
| XLV | PINK | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SPDR (State Street) | Simplify Exchange Traded |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.08% | 0.51% |
| Annual cost per $10k | $8 | $51 |
| 10-yr cost on $10k (prospectus) | $103 | $641 |
| Max front load | None | None |
| 12b-1 fee | 0.02% | 0% |
| 1-yr return | +14.5% | +24.1% |
| 5-yr return (annualized) | +8.1% | — |
| 10-yr return (annualized) | +9.8% | — |
| Best quarter | +14.5% | +15.6% |
| Worst quarter | −12.7% | −9.5% |
| Net assets (fund) | $40.6B | $358.6M |
| Number of holdings | 65 | 54 |
| Portfolio turnover | 2% | 171% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | XLV | PINK | Difference |
|---|---|---|---|
| 2025 | +14.5% | +24.1% | −9.6% |
| 2024 | +2.5% | +8.9% | −6.4% |
| 2023 | +2.0% | +3.8% | −1.8% |
| 2022 | −2.1% | −4.3% | +2.2% |
Source: Fund prospectus bar charts
Holdings overlap
12 of XLV's top 25 holdings also appear in PINK's top 25.
| Holding | XLV | PINK |
|---|---|---|
| Eli Lilly & Co | 16.51% | 5.91% |
| Johnson & Johnson | 10.64% | 5.45% |
| AbbVie Inc | 7.74% | 4.52% |
| UnitedHealth Group Inc | 6.57% | 5.76% |
| Amgen Inc | 3.40% | 2.12% |
| Thermo Fisher Scientific Inc | 3.24% | 3.23% |
| Gilead Sciences Inc | 2.73% | 2.87% |
| CVS Health Corp | 2.30% | 2.01% |
| Vertex Pharmaceuticals Inc | 2.19% | 1.45% |
| Danaher Corp | 2.09% | 2.28% |
| Elevance Health Inc | 1.46% | 2.73% |
| Cardinal Health Inc | 0.97% | 1.78% |
Source: SEC Form N-PORT
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
PINK top 10
- Purecycle Technologies Inc — 6.89%
- United Therapeutics Corp — 6.86%
- Novo Nordisk A/s — 6.75%
- Eli Lilly & Company — 5.91%
- Unitedhealth Group Inc — 5.76%
- Warby Parker Inc — 5.46%
- Johnson & Johnson — 5.45%
- Jazz Pharmaceuticals Plc — 4.61%
- Abbvie Inc — 4.52%
- Biohaven Ltd — 4.32%
FAQ
What is the difference between XLV and PINK?
Which is cheaper, XLV or PINK?
Should I own both XLV and PINK?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.